1063 related articles for article (PubMed ID: 1657650)
41. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
42. The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ.
Song HM; Styblo TM; Carlson GW; Losken A
Breast J; 2010; 16(2):141-6. PubMed ID: 20102367
[TBL] [Abstract][Full Text] [Related]
43. Lobular carcinoma of the breast in situ and infiltrating.
Wheeler JE; Enterline HT
Pathol Annu; 1976; 11():161-88. PubMed ID: 188001
[TBL] [Abstract][Full Text] [Related]
44. Review of re-excision for narrow or positive margins of invasive and intraductal carcinoma.
Gupta A; Subhas G; Dubay L; Silapaswan S; Kolachalam R; Kestenberg W; Ferguson L; Jacobs MJ; Gorieil Y; Mittal VK
Am Surg; 2010 Jul; 76(7):731-4. PubMed ID: 20698380
[TBL] [Abstract][Full Text] [Related]
45. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
[TBL] [Abstract][Full Text] [Related]
46. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ
Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619
[TBL] [Abstract][Full Text] [Related]
47. Breast-conserving therapy of ductal carcinoma in situ: frequency of local recurrence after wide excision with and without additional radiotherapy, a retrospective study of 42 cases.
Vrouenraets BC; Peterse JL; van Dongen JA
Neth J Surg; 1991 Jun; 43(3):51-5. PubMed ID: 1656327
[TBL] [Abstract][Full Text] [Related]
48. Recent trends in the management of breast cancer. 1. Carcinoma in situ of the breast.
Donegan WL
Can J Surg; 1992 Aug; 35(4):361-5. PubMed ID: 1323379
[TBL] [Abstract][Full Text] [Related]
49. Lobular carcinoma in situ/atypical lobular hyperplasia on breast needle biopsies: does it warrant surgical excisional biopsy? A study of 27 cases.
O'Neil M; Madan R; Tawfik OW; Thomas PA; Fan F
Ann Diagn Pathol; 2010 Aug; 14(4):251-5. PubMed ID: 20637429
[TBL] [Abstract][Full Text] [Related]
50. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
51. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility.
Destounis SV; Murphy PF; Seifert PJ; Somerville PA; Arieno AL; Morgan RC; Young WL
AJR Am J Roentgenol; 2012 Feb; 198(2):281-7. PubMed ID: 22268169
[TBL] [Abstract][Full Text] [Related]
52. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
Berg WA; Mrose HE; Ioffe OB
Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
[TBL] [Abstract][Full Text] [Related]
53. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
[TBL] [Abstract][Full Text] [Related]
54. Ultrasonography- and/or mammography-guided breast conserving surgery for ductal carcinoma in situ of the breast: experience with 87 lesions.
Hayashi N; Tsunoda H; Abe E; Kikuchi M; Enokido K; Tsugawa K; Suzuki K; Nakamura S
Breast Cancer; 2012 Apr; 19(2):131-7. PubMed ID: 20725871
[TBL] [Abstract][Full Text] [Related]
55. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies.
Gao F; Carter G; Tseng G; Chivukula M
Am J Clin Pathol; 2010 May; 133(5):767-71. PubMed ID: 20395524
[TBL] [Abstract][Full Text] [Related]
56. [Breast cancer in males: a study of 15 cases of pure ductal carcinoma in situ].
Cutuli BF; Florentz P; Lacroze M; Dilhuydy JM; Allavena C; De Lafontan B; Resbeut M; Campana F; Graic Y; Tortochaux J
Bull Cancer; 1992; 79(11):1045-53. PubMed ID: 1338868
[TBL] [Abstract][Full Text] [Related]
57. Second events following ductal carcinoma in situ of the breast: a register-based cohort study.
Falk RS; Hofvind S; Skaane P; Haldorsen T
Breast Cancer Res Treat; 2011 Oct; 129(3):929-38. PubMed ID: 21537936
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
Evans WP; Starr AL; Bennos ES
Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
[TBL] [Abstract][Full Text] [Related]
59. The early detection of nonpalpable breast carcinoma with needle localization. Experience with 500 patients in a community hospital.
Miller RS; Adelman RW; Espinosa MH; Dorman SA; Smith DH
Am Surg; 1992 Mar; 58(3):193-8. PubMed ID: 1313665
[TBL] [Abstract][Full Text] [Related]
60. Flat ductal intraepithelial neoplasia 1A diagnosed at stereotactic core needle biopsy: is excisional biopsy indicated?
Becker AK; Gordon PB; Harrison DA; Hassell PR; Hayes MM; van Niekerk D; Wilson CM
AJR Am J Roentgenol; 2013 Mar; 200(3):682-8. PubMed ID: 23436863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
